Condensed Consolidated Statements of Comprehensive Loss (Parenthetical) - USD ($) $ in Thousands |
3 Months Ended | 9 Months Ended | ||
|---|---|---|---|---|
Sep. 30, 2021 |
Sep. 30, 2020 |
Sep. 30, 2021 |
Sep. 30, 2020 |
|
| Total stock-based compensation expense | $ 14,069 | $ 11,596 | $ 40,791 | $ 36,915 |
| Cost of revenues | ||||
| Total stock-based compensation expense | 2,728 | 2,110 | 8,026 | 7,422 |
| Sales and marketing | ||||
| Total stock-based compensation expense | 2,885 | 2,209 | 8,352 | 6,353 |
| Research and development | ||||
| Total stock-based compensation expense | 3,388 | 2,901 | 10,039 | 9,780 |
| General and administrative | ||||
| Total stock-based compensation expense | $ 5,068 | $ 4,376 | $ 14,374 | $ 13,360 |